Impact of pharmaceutical care on adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia Betel Del Rosario García, Vina Romero, Gonzalez Rosa, Alarcon Payer, Leonor Oliva Oliva, Gloria Julia Nazco Casariego, Gutierrez Nicolas

Adjusted indirect comparison of zanubrutinib and ibrutinib in first-line treatment of chronic lymphocytic leukemia Salmeron-Navas, Barreiro-Fernandez, Fenix-Caballero

Adherence and quality of life in patients with chronic lymphocytic leukemia treated with oral antineoplastic drugs María Ochagavía Sufrategui, María Ángeles Gil Lemus, Lucrecia Yáñez San Segundo, Carlos Antonio Amado Diago, Sara Barbadillo Villanueva, Virginia Martínez Callejo, María Victoria Villacañas Palomares, Marta Valero Domínguez